We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News   Feb 12, 2018

 
Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Credit: Horizon

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project

Product News

Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance.

READ MORE

Breast Cancer Device Receives FDA Approval

Product News

The first non-radioactive, dual-tracer for sentinel lymph node biopsy approved in the U.S.

READ MORE

Fluidic Analytics Secures US Patent for Next-generation Protein Analysis Technology Platform

Product News

This paves the way for the development and commercialisation of a next-generation protein analysis technology platform to be launched later this year.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE